Print Page      Close Window     
424B4
IQIYI, INC. filed this Form 424B4 on 03/29/2018
Entire Document
 


Table of Contents

The following table summarizes, as of the date of this prospectus, the outstanding options that we granted to our directors and executive officers:

 

Name

   Ordinary Shares
Underlying Outstanding
Options
     Exercise Price
($/Share)
    

Grant Date

  

Expiration Date

Robin Yanhong Li

     —          —        —      —  

Qi Lu

     —          —        —      —  

Yu Gong

     109,904,462        0.25 to 0.51      Various dates from October 18, 2010 to February 28, 2018    Various dates from October 17, 2020 to February 27, 2028

Herman Yu

     —          —        —      —  

Lu Wang

     —          —        —      —  

Sam Hanhui Sun

     —          —        —      —  

Chuan Wang

     —          —        —      —  

Xiaodong Wang

     *        0.51      February 23, 2015 and February 28, 2018    February 22, 2025 and February 27, 2028

Xiaohui Wang

     *        0.51      August 5, 2016 and February 28, 2018    August 4, 2026 and February 27, 2028

Xing Tang

     *        0.25 to 0.51      Various dates from December 15, 2014 to February 28, 2018    Various dates from December 14, 2024 to February 27, 2028

Xiangjun Wang

     *        0.25 to 0.51      Various dates from October 18, 2010 to February 28, 2018    Various dates from October 17, 2020 to February 27, 2028

Xianghua Yang

     *        0.25 to 0.51      Various dates from October 18, 2010 to February 28, 2018    Various dates from October 17, 2020 to February 27, 2028

Youqiao Duan

     *        0.25 to 0.51      Various dates from May 8, 2012 to February 28, 2018    Various dates from May 7, 2022 to February 27, 2028

Total

    
205,104,462
 
     0.25 to 0.51      Various dates from October 18, 2010 to February 28, 2018    Various dates from October 17, 2020 to February 27, 2028

 

* Less than 1% of our total ordinary shares outstanding assuming conversion of all preferred shares into ordinary shares.

As of the date of this prospectus, other grantees as a group held options to purchase 193,259,116 Class A ordinary shares of our company, with exercise prices ranging from US$0.25 to US$0.51 per share, and 720,000 restricted share units.

 

149